| Dr John A Fegurgur, MD | |
|
280 Pale San Vitores Rd, Tamuning, GU 96913-3615 | |
| (671) 647-4542 | |
| (671) 647-4558 |
| Full Name | Dr John A Fegurgur |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 32 Years |
| Location | 280 Pale San Vitores Rd, Tamuning, Guam |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487623856 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | MOO1223 (Guam) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Guam Memorial Hospital Authority | Tamuning, GU | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Medical Center, Llc | 1759311699 | 16 |
News Archive
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
They conclude that a survey of masonry buildings from that era is necessary to determine where in the U.S. these materials had been used, and that caulking should be routinely analyzed for PCBs and managed appropriately to reduce potentially significant health risks.
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
The St. Petersburg-Times: Three complaints by whistleblowers suing WellCare Health Plans Inc. have been unsealed in recent days as part of a federal probe into the company's operations. Federal officials raided the company offices in 2007. In the most recent complaints, "Clark J. Bolton, a former supervisor of special investigations at WellCare, said the insurer encouraged overbilling and refused to audit claims for fraud in order to curry favor with doctors and hospitals and build market share.
› Verified 7 days ago
| Entity Name | Hafa Specialist Group Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235141060 PECOS PAC ID: 3779482286 Enrollment ID: O20040105000249 |
News Archive
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
They conclude that a survey of masonry buildings from that era is necessary to determine where in the U.S. these materials had been used, and that caulking should be routinely analyzed for PCBs and managed appropriately to reduce potentially significant health risks.
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
The St. Petersburg-Times: Three complaints by whistleblowers suing WellCare Health Plans Inc. have been unsealed in recent days as part of a federal probe into the company's operations. Federal officials raided the company offices in 2007. In the most recent complaints, "Clark J. Bolton, a former supervisor of special investigations at WellCare, said the insurer encouraged overbilling and refused to audit claims for fraud in order to curry favor with doctors and hospitals and build market share.
› Verified 7 days ago
| Entity Name | American Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457329849 PECOS PAC ID: 1759311699 Enrollment ID: O20050819000498 |
News Archive
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
They conclude that a survey of masonry buildings from that era is necessary to determine where in the U.S. these materials had been used, and that caulking should be routinely analyzed for PCBs and managed appropriately to reduce potentially significant health risks.
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
The St. Petersburg-Times: Three complaints by whistleblowers suing WellCare Health Plans Inc. have been unsealed in recent days as part of a federal probe into the company's operations. Federal officials raided the company offices in 2007. In the most recent complaints, "Clark J. Bolton, a former supervisor of special investigations at WellCare, said the insurer encouraged overbilling and refused to audit claims for fraud in order to curry favor with doctors and hospitals and build market share.
› Verified 7 days ago
| Entity Name | Guam X-ray |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376767426 PECOS PAC ID: 8123180742 Enrollment ID: O20210325002365 |
News Archive
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
They conclude that a survey of masonry buildings from that era is necessary to determine where in the U.S. these materials had been used, and that caulking should be routinely analyzed for PCBs and managed appropriately to reduce potentially significant health risks.
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
The St. Petersburg-Times: Three complaints by whistleblowers suing WellCare Health Plans Inc. have been unsealed in recent days as part of a federal probe into the company's operations. Federal officials raided the company offices in 2007. In the most recent complaints, "Clark J. Bolton, a former supervisor of special investigations at WellCare, said the insurer encouraged overbilling and refused to audit claims for fraud in order to curry favor with doctors and hospitals and build market share.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John A Fegurgur, MD 280 Pale San Vitores Rd, Tamuning, GU 96913-3615 Ph: (671) 647-4542 | Dr John A Fegurgur, MD 280 Pale San Vitores Rd, Tamuning, GU 96913-3615 Ph: (671) 647-4542 |
News Archive
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
They conclude that a survey of masonry buildings from that era is necessary to determine where in the U.S. these materials had been used, and that caulking should be routinely analyzed for PCBs and managed appropriately to reduce potentially significant health risks.
For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms.
The St. Petersburg-Times: Three complaints by whistleblowers suing WellCare Health Plans Inc. have been unsealed in recent days as part of a federal probe into the company's operations. Federal officials raided the company offices in 2007. In the most recent complaints, "Clark J. Bolton, a former supervisor of special investigations at WellCare, said the insurer encouraged overbilling and refused to audit claims for fraud in order to curry favor with doctors and hospitals and build market share.
› Verified 7 days ago
Ronald T Kobayashi, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 590 South Marine Corps Drive, Gitc Biulding Ste 211, Tamuning, GU 96913 Phone: 671-649-7588 Fax: 671-646-1088 | |
Dr. Michael W Cruz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Farenholt Ave, Tamuning, GU 96913 Phone: 671-646-0443 Fax: 671-646-0440 | |
Jerone Theodore Landstrom, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 633 Gov Carlos Camacho Road, Suite 104 Guam Medical Plaza, Tamuning, GU 96913 Phone: 671-646-4263 Fax: 671-649-1019 | |
Dr. Melany Camille Hughes, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 280 Pale San Vitores Rd, Hafa Adai Specialist Group, Tamuning, GU 96913 Phone: 671-647-4542 | |
Dr. Christian Ada Eusebio, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Farenholt Ave, Tamuning, GU 96913 Phone: 671-646-0441 | |
Mr. Ricardo Brownlee Eusebio, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 633 Gov Carlos Camacho Road, Ste 202, Tamuning, GU 86913 Phone: 671-646-0443 Fax: 671-646-0440 |